このエントリーをはてなブックマークに追加
ID 69174
FullText URL
fulltext.pdf 3.36 MB
suppl1.tiff 234 KB
suppl2.tiff 681 KB
suppl3.tiff 377 KB
suppl4.pdf 174 KB
Author
Ishiguro, Mikako Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Takahara, Masahiro Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Takaki, Akinobu Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine Kaken ID publons researchmap
Hiraoka, Sakiko Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine Kaken ID publons researchmap
Toyosawa, Jyunki Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Aoyama, Yuki Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Igawa, Shoko Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Yamasaki, Yasushi Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine ORCID Kaken ID publons
Inokuchi, Toshihiro Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Kinugasa, Hideaki Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine ORCID Kaken ID
Otsuka, Motoyuki Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Abstract
Background Nonsteroidal anti-inflammatory drugs (NSAID), which are commonly used to manage pain and inflammation, often cause gastrointestinal injuries, including small intestinal damage. Berberine (BBR) is a traditional Chinese medicine that protects against these injuries. However, the mechanism of action is not fully understood.
Aims This study aimed to evaluate the protective effects of BBR against NSAID-induced intestinal injury and elucidate the underlying molecular mechanisms.
Methods We evaluated the effects of BBR on NSAID-induced intestinal injury using a combination of mouse models and human gut organoids. Mice were treated with indomethacin with or without BBR to induce small intestinal injury. Human gut organoids were exposed to NSAID, with or without BBR, to assess their direct epithelial effects. Histological analyses, cytokine measurements, and Western blotting were performed to evaluate intestinal damage, tight junction integrity, and inflammasome-associated activation.
Results In NSAID-treated mice, BBR markedly reduced ulcers and adhesions and preserved ileal Claudin-1, Occludin, and Zonula Occludens-1 (ZO-1) levels. BBR inhibited both NOD-like receptor family pyrin domain-containing 6 and NOD-like receptor family caspase recruitment domain–containing protein 4 inflammasome activation, reducing Caspase-1 maturation and downstream interleukin-1β and tumor necrosis factor-α release. In human gut organoids, BBR demonstrated comparable protective effects by directly mitigating NSAID-induced epithelial barrier disruption caused by Claudin-1 and Occludin downregulation, although it did not restore ZO-1 expression.
Conclusions BBR effectively prevented NSAID-induced small intestinal injury by maintaining tight junction integrity and inhibiting inflammasome-associated activation, indicating its potential as a therapeutic agent against such damage.
Keywords
Nonsteroidal anti-inflammatory drugs-induced small intestinal injury
Berberine
Tight junction protein
Inflammasomes
Note
The version of record of this article, first published in Digestive Diseases and Sciences, is available online at Publisher’s website: http://dx.doi.org/10.1007/s10620-025-09276-5
Published Date
2025-08-02
Publication Title
Digestive Diseases and Sciences
Publisher
Springer Science and Business Media LLC
ISSN
0163-2116
NCID
AA00161107
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© The Author(s) 2025
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1007/s10620-025-09276-5
License
http://creativecommons.org/licenses/by-nc/4.0/
Citation
Ishiguro, M., Takahara, M., Takaki, A. et al. Berberine Prevents NSAID-Induced Small Intestinal Injury by Protecting Intestinal Barrier and Inhibiting Inflammasome-Associated Activation. Dig Dis Sci (2025). https://doi.org/10.1007/s10620-025-09276-5
助成情報
( 国立大学法人岡山大学 / Okayama University )
20K16957: CD4T細胞の代謝制御を標的にした炎症性腸疾患新規治療薬の開発 ( 文部科学省 / Ministry of Education )
202310009: ( 公益財団法人三菱財団 / Mitsubishi Foundation )